PCM
ABBV icon

Princeton Capital Management’s AbbVie ABBV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.33M Sell
7,167
-934
-12% -$173K 0.4% 40
2025
Q1
$1.7M Hold
8,101
0.6% 28
2024
Q4
$1.44M Sell
8,101
-826
-9% -$147K 0.45% 38
2024
Q3
$1.76M Sell
8,927
-1,170
-12% -$231K 0.56% 34
2024
Q2
$1.73M Sell
10,097
-95
-0.9% -$16.3K 0.56% 33
2024
Q1
$1.86M Sell
10,192
-75
-0.7% -$13.7K 0.67% 34
2023
Q4
$1.59M Sell
10,267
-22,626
-69% -$3.51M 0.64% 36
2023
Q3
$4.9M Sell
32,893
-6,339
-16% -$945K 2.26% 10
2023
Q2
$5.29M Sell
39,232
-59
-0.2% -$7.95K 2.19% 10
2023
Q1
$6.26M Sell
39,291
-5,443
-12% -$867K 2.68% 8
2022
Q4
$7.23M Sell
44,734
-4,919
-10% -$795K 3.21% 6
2022
Q3
$6.66M Sell
49,653
-92
-0.2% -$12.3K 2.92% 7
2022
Q2
$7.62M Buy
49,745
+828
+2% +$127K 2.95% 8
2022
Q1
$7.93M Sell
48,917
-562
-1% -$91.1K 2.46% 9
2021
Q4
$6.7M Buy
49,479
+59
+0.1% +$7.99K 1.92% 15
2021
Q3
$5.33M Buy
49,420
+176
+0.4% +$19K 1.7% 17
2021
Q2
$5.55M Buy
49,244
+61
+0.1% +$6.87K 1.72% 18
2021
Q1
$5.32M Buy
49,183
+192
+0.4% +$20.8K 1.8% 18
2020
Q4
$5.25M Buy
48,991
+1,649
+3% +$177K 1.88% 18
2020
Q3
$4.15M Buy
47,342
+1,204
+3% +$105K 1.67% 20
2020
Q2
$4.53M Buy
46,138
+1,832
+4% +$180K 2.01% 18
2020
Q1
$3.79M Buy
44,306
+2,385
+6% +$204K 1.97% 17
2019
Q4
$3.87M Buy
41,921
+167
+0.4% +$15.4K 1.73% 21
2019
Q3
$3.16M Sell
41,754
-1,680
-4% -$127K 1.54% 21
2019
Q2
$3.16M Sell
43,434
-1,030
-2% -$74.9K 1.54% 23
2019
Q1
$3.58M Buy
44,464
+12,085
+37% +$974K 1.81% 19
2018
Q4
$2.99M Sell
32,379
-11,191
-26% -$1.03M 1.74% 22
2018
Q3
$4.12M Buy
43,570
+17,472
+67% +$1.65M 1.71% 22
2018
Q2
$2.42M Buy
26,098
+965
+4% +$89.4K 1.05% 28
2018
Q1
$2.38M Sell
25,133
-1,352
-5% -$128K 1.06% 30
2017
Q4
$2.56M Buy
+26,485
New +$2.56M 1.14% 29